125 related articles for article (PubMed ID: 15154310)
1. [The microbial safety of transfusion products].
Mäki T; Krusius T
Duodecim; 2004; 120(7):885-92. PubMed ID: 15154310
[No Abstract] [Full Text] [Related]
2. [Blood transfusion safety].
Koistinen J
Duodecim; 2004; 120(7):902-4. PubMed ID: 15154312
[No Abstract] [Full Text] [Related]
3. Decreasing the risk of allogenic blood in the 21st century.
Popovsky MA; O'Neill EM; Cannon M
Med Health R I; 1998 Dec; 81(12):392-5. PubMed ID: 9884538
[No Abstract] [Full Text] [Related]
4. Management of donors and blood products reactive for hepatitis B virus DNA.
Reesink HW; Allain JP
Vox Sang; 2006 Nov; 91(4):281. PubMed ID: 17105601
[No Abstract] [Full Text] [Related]
5. [Prophylactic platelet transfusion in patients with hematologic diseases].
Siitonen T; Koistinen P
Duodecim; 2004; 120(7):877-84. PubMed ID: 15154309
[No Abstract] [Full Text] [Related]
6. [Exercise is good for your health, but is it safe?].
Parkkari J
Duodecim; 2005; 121(12):1269-71. PubMed ID: 16134504
[No Abstract] [Full Text] [Related]
7. Reengineering transfusion and cellular therapy processes hospitalwide: ensuring the safe utilization of blood products.
Brooks JP
Transfusion; 2005 Oct; 45(4 Suppl):159S-71S. PubMed ID: 16181401
[TBL] [Abstract][Full Text] [Related]
8. Risk assessment for prevention of morbidity and mortality: lessons for pressure ulcer prevention.
Reynolds TM
J Tissue Viability; 2008 Nov; 17(4):115-20. PubMed ID: 19061825
[TBL] [Abstract][Full Text] [Related]
9. [Risks and risk factors of blood transfusion].
Pihkala U
Duodecim; 2005; 121(19):2125, author reply 2125. PubMed ID: 16300304
[No Abstract] [Full Text] [Related]
10. Transfusion-Transmitted Infections: an Update on Product Screening, Diagnostic Techniques, and the Path Ahead.
Dean CL; Wade J; Roback JD
J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29669792
[TBL] [Abstract][Full Text] [Related]
11. Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events.
Dennison CR; Hughes S
J Cardiovasc Nurs; 2009; 24(1):18-20. PubMed ID: 19114796
[No Abstract] [Full Text] [Related]
12. The future of cancer prevention.
Greenwald P
Semin Oncol Nurs; 2005 Nov; 21(4):296-8. PubMed ID: 16293518
[TBL] [Abstract][Full Text] [Related]
13. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003.
Coste J; Reesink HW; Engelfriet CP; Laperche S; Brown S; Busch MP; Cuijpers HT; Elgin R; Ekermo B; Epstein JS; Flesland O; Heier HE; Henn G; Hernandez JM; Hewlett IK; Hyland C; Keller AJ; Krusius T; Levicnik-Stezina S; Levy G; Lin CK; Margaritis AR; Muylle L; Niederhauser C; Pastila S; Pillonel J; Pineau J; van der Poel CL; Politis C; Roth WK; Sauleda S; Seed CR; Sondag-Thull D; Stramer SL; Strong M; Vamvakas EC; Velati C; Vesga MA; Zanetti A
Vox Sang; 2005 May; 88(4):289-303. PubMed ID: 15877653
[No Abstract] [Full Text] [Related]
14. Should low bone mass be treated?
Miller PD
Int J Fertil Womens Med; 2005; 50(2):83-7. PubMed ID: 16334416
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form.
Luksamijarulkul P; Thammata N; Sujirarat D; Tiloklurs M
Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):147-54. PubMed ID: 15272759
[TBL] [Abstract][Full Text] [Related]
16. Effect of preventive applications on prevalence of hepatitis B virus and hepatitis C virus infections in West Turkey.
Sakarya S; Oncu S; Ozturk B; Oncu S
Saudi Med J; 2004 Aug; 25(8):1070-2. PubMed ID: 15322600
[TBL] [Abstract][Full Text] [Related]
17. [Special features of blood transfusion to children].
Salonvaara M
Duodecim; 2004; 120(7):860-5. PubMed ID: 15154307
[No Abstract] [Full Text] [Related]
18. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
Erhabor O; Ejele OA; Nwauche CA
Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
[TBL] [Abstract][Full Text] [Related]
19. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
20. Transfusion safety: Where are we today?
Luban NL
Ann N Y Acad Sci; 2005; 1054():325-41. PubMed ID: 16339681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
